Saturday, October 10, 2015: 8:30 AM-10:00 AM
Room: 28--ABCDE
Learning Objectives:
At the conclusion of this session, participants will be able to:
- recognize the role of inflammation as a cause of disease in HIV-infected patients and upcoming treatment advances that may improve patient care
- summarize advances in our understanding of the microbiome in HIV-infected patients and how that research may affect treatment HIV
- evaluate causes of cardiovascular disease and options for prevention of cardiovascular disease in HIV-infected patients
Target Audience: Researchers, Members-in-training, Infectious diseases physicians, Infectious diseases pediatricians, HIV specialists, HIV clinicians, Clinicians, Academicians
Tracks: HIV-STD-TB, Adult ID, Trainee
Moderators:
Rajesh Gandhi, MD, FIDSA, Massachusetts General Hospital and Ragon Institute
and
Ighovwerha Ofotokun, MD, MSc, FIDSA, Emory University School of Medicine
Presentations:
9:00 AM
Inflammation and Microbiomes in HIV-Infected Patients: Recent Updates and Potential Clinical Implications
Douglas Kwon, MD, PhD
Douglas Kwon, MD, PhD
9:30 AM
CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM
ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE
ACPE Number: 0221-9999-15-192-L01-P
Disclosures:
R. Gandhi,
Gilead:
Recipient of educational grant
,
Educational grant
EBSCO:
Educational grant recipient
,
Educational grant
Roche:
Educational grant recipient
,
Educational grant
See more of: Symposium